Evaluation of Serum Vascular Adhesion Protein-1 as a Potential Biomarker in Thyroid Cancer

Figure 1

Serum level of VAP-1 in patients and healthy controls. VAP-1 concentrations were measured in serum from healthy controls (), patients with benign thyroid nodules (), and patients with thyroid cancer (). Scatter graphs were plotted to demonstrate the intergroup differences of presurgical serum VAP-1 in patients as well as in control subjects. Data are presented as mean ± SD. .